Avara Liscate Pharmaceutical Services
Italy
Program data pending ClinicalTrials.gov matching
Profiled
Not yet scored
✓ FDA Inspections (3)
○ Clinical Trials
○ SEC Filings
○ Press
✓ EMA GMP (3)
○ MHRA GMP
✓ HC GMP (2)
Quick Facts: Avara Liscate Pharmaceutical Services
- Signal Score
- Profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed. How scoring works
- Headquarters
- Italy
- Website
- https://www.avara.com/
- Modalities
- Oral Solid Dose, Sterile Fill-Finish
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
About Avara Liscate Pharmaceutical Services
Avara Liscate Pharmaceutical Services is a contract development and manufacturing organization (CDMO). Capabilities: Oral Solid Dose, Sterile Fill-Finish. 1 manufacturing site registered with the U.S. FDA and Health Canada. Website: https://www.avara.com/
Signal Score
Profiled, not yet scored.
Scores are published after regulatory evidence is attached and reviewed.
How scoring works
Avara Liscate Pharmaceutical Services FDA Inspection History
2026-02
2023-06
2022-12
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2026-02-20 |
Avara Liscate Pharmaceutical Services SPA
Liscate
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
| 2023-06-09 |
Avara Liscate Pharmaceutical Services SPA
Liscate
Company-level
|
Drug Quality Assurance | No | Voluntary Action Indicated (VAI) |
| 2022-12-06 |
Avara Liscate Pharmaceutical Services SPA
Liscate
Company-level
|
Drug Quality Assurance | Yes | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Oct 31, 2026
Avara Liscate Pharmaceutical Services FDA 483 Findings 3 observations · 2022-12-06 → 2022-12-06 ?
By subsystem
By severity
- 3 — Moderate: 1
- 2 — Minor: 2
- Repeat observations: 0
Most severe findings
-
Written record of investigation incomplete
"Written records of investigations into unexplained discrepancies do not include the conclusions and follow-up."
-
Equipment for Environmental Control
"Equipment for adequate control over micro-organisms is not provided when appropriate for the manufacture, processing, packing or holding of a drug product."
-
Batch production and Batch Control Record Requirements
"The batch production and control records are deficient in that they do not include documentation of the accomplishment of each significant step in manufacturing."
Avara Liscate Pharmaceutical Services EMA GMP Compliance 3 certificates
2026-02
2016-02
2016-02
Compliant
Non-Compliant
| Certificate | Site | Country | Inspection Date | Status |
|---|---|---|---|---|
| IT/105/H/2026 | Avara Liscate Pharmaceutical Services S.p.A. | Italy | 2026-02-20 | COMPLIANT |
| IT-API/165/H/2019 | AVARA LISCATE PHARMACEUTICAL SERVICES S.p.A. | Italy | 2016-02-02 | COMPLIANT |
| IT-API/218/H/2022 | Avara Liscate Pharmaceutical Services S.p.A. | Italy | 2016-02-02 | COMPLIANT |
Source: EMA EudraGMDP · Retrieved Oct 31, 2026
Hiring Activity Beta
Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source:
public careers pages
· Checked Oct 30, 2026
Frequently Asked Questions About Avara Liscate Pharmaceutical Services
How many FDA inspections does Avara Liscate Pharmaceutical Services have on record?
CDMO Signal tracks 3 FDA inspections for Avara Liscate Pharmaceutical Services, sourced from the FDA inspection database. See the full inspection history above.
Has Avara Liscate Pharmaceutical Services received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Avara Liscate Pharmaceutical Services.
Does Avara Liscate Pharmaceutical Services hold EMA or MHRA GMP certificates?
CDMO Signal tracks 3 EMA GMP certificates for Avara Liscate Pharmaceutical Services.
Does Avara Liscate Pharmaceutical Services have a CDMO Signal Score?
Not yet. Avara Liscate Pharmaceutical Services is profiled, not yet scored. Scores are published after regulatory evidence is attached and reviewed.
Evaluating Avara Liscate Pharmaceutical Services for a manufacturing program?
Use the free AI matchmaker to compare Avara Liscate Pharmaceutical Services against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
Similar CDMOs
Latina Pharma
Sermoneta (Latina), Italy
Small Molecule API, Oncology Products, Sterile Fill-Finish, Lyophilization, Oral Solid Dose
Vetio Animal Health
United States
Oral Solid Dose, Semi-solids & Liquids, Sterile Fill-Finish
Shilpa Medicare
India (registered sites)
Small Molecule API, Oral Solid Dose, Sterile Fill-Finish, Biologics, Peptides & Oligos
Acme Formulation
Nalagarh (Himachal Pradesh), India
Oral Solid Dose, Semi-solids & Liquids, Sterile Fill-Finish
Alcami Carolinas
United States
Oral Solid Dose, Sterile Fill-Finish, Small Molecule API
Compare Avara Liscate Pharmaceutical Services with another CDMO
Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.